UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between breast cancer and ovarian cancer clinical trials and research opportunities
The most common cancer in UK women, with ~55,000 new cases annually. Treatment pathways are well-established with strong clinical trial availability across HER2+, HR+, and TNBC subtypes.
Often called the "silent killer" due to late diagnosis. Around 7,500 new UK cases per year. PARP inhibitor trials are a major growth area, especially for BRCA-positive patients.
Breast cancer has more trial options due to higher incidence and established biomarker testing. Ovarian cancer trials focus heavily on genetic markers (BRCA1/2) and maintenance therapy.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
